This post on IntraHealth International’s “Global Health Blog” discusses a new report (.pdf) from the WHO, titled “Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination,” which “concludes that ‘all countries should commit to spend at least 0.01 percent of GDP on government-funded R&D [research and development] devoted to meeting the health needs of developing countries.'” The post states, “The report has a double significance. First, it is a vigorous statement of the need for a binding agreement on health innovation to address diseases that mostly affect developing countries. Second, it is an important concrete step on the long path to it” (Chiscop, 4/13).
Private Sector Involvement
“Individuals, businesses and foundations have continued to give money to humanitarian and development organizations despite harsh economic times, providing a crucial source of funding in the face of declining official aid,” according to a report on private aid funding by the monitoring group Global Humanitarian Assistance (GHA), the Guardian reports. The news service writes, “According to the report, 24 percent of the international humanitarian response from 2006 to 2010” — at least $18 billion — “came from private voluntary contributions”; “[i]n 2010 alone, $5.8 billion was donated privately, mainly in response to the earthquake in Haiti and the floods in Pakistan”; and “[a]s a share of the total humanitarian response, private funding grew from 17 percent in 2006 to 32 percent in 2010.”
“Canada’s foreign aid agency will work with Grand Challenges Canada in a bid to bring ideas for health innovation to the developing world, International Co-operation Minister Julian Fantino says,” the Globe and Mail reports. “Fantino announced the partnership with the federally funded group Tuesday morning as he opened a multi-day Grand Challenges Canada meeting in Ottawa,” the newspaper notes, adding, “Fantino used his opening speech to tout Canada’s contribution to maternal and child health through its landmark Muskoka Initiative and call for new ideas that can help increase maternal and child survival.”
Vaccines “save lives by protecting people against disease,” but they “also are an engine for economic growth — far beyond their health benefits,” GAVI Alliance CEO Seth Berkley writes in a CNN opinion piece. GAVI and its “many partners, including prominent companies,” “recognize that in addition to the humanitarian need, countries such as Tanzania are emerging markets that can fulfill their economic ambitions only if they also can ensure good health for their citizens,” he states. Berkley describes efforts to increase vaccination rates in Tanzania, and he writes, “[W]e know for a fact that vaccines — in addition to saving lives and improving health — are the cornerstone of a vibrant economy, fuel growth and serve as a magnet for foreign investment. Indeed, research has shown vaccines to be among the most cost-effective investments in global development.”
“British mobile phone group Vodafone and drug maker GlaxoSmithKline are joining forces on a novel project to increase childhood vaccination rates in Mozambique using text messaging,” Reuters reports. With the aim of increasing the proportion of children covered by vaccination by five to 10 percent, a one-year pilot project supported by Save the Children “will register mothers on a ministry of health database, alert them to the availability of vaccinations and allow them to schedule appointments by text,” the news agency notes. In addition, a three-year partnership between Vodafone and the GAVI Alliance, supported by the British government, will “study how health ministries across sub-Saharan Africa can use mobile technology to improve their immunization programs,” Reuters notes, adding, “Britain will match Vodafone’s contribution of technology and services with a $1.5 million cash contribution to GAVI” (12/10).
“In an effort to fight the human papillomavirus (HPV), the leading cause of cervical cancer, more than 30 million girls will be immunized against HPV by 2020 with GAVI support, the global health alliance announced on Thursday,” Xinhua/Global Times reports. “Rwanda and Uganda have been conducting HPV pilot projects through donations from vaccine manufacturers and are expected to roll out the vaccine nationwide with GAVI support in 2014,” the news service writes, adding, “By 2015, GAVI plans to immunize approximately one million girls with HPV vaccines and a large number of other countries are expected to run HPV pilot projects, and by 2020, more than 30 million girls will be immunized against HPV, [GAVI Alliance CEO Seth] Berkley said” (12/7).
Several blogs recently reported on issues discussed last week during a conference sponsored by Medecins Sans Frontieres (MSF), the Drugs for Neglected Diseases initiative (DNDi), and the Mount Sinai School of Medicine in New York, titled “Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations.” The following is a list of those posts.
Nick Chapman, a policy analyst at Policy Cures, writes in a guest post on the Global Health Technologies Coalition’s “Breakthroughs” blog about “the results of the latest G-FINDER survey on global funding of [research and development (R&D)] for neglected diseases.” He discusses several findings and trends from the report, including the impact of the global financial recession on R&D funding; the relatively stable level of U.S. funding; the concentration of pharmaceutical company funding to “a limited number of diseases with some commercial overlap, such as dengue fever, bacterial pneumonia and meningitis, and tuberculosis (TB)”; the shift away from product development funding from public funders; and the effect of these trends on product development partnerships (PDPs) (Lufkin, 12/19).
“Twenty years ago this month, the first text message was sent through the airwaves,” Sharon D’Agostino, vice president for worldwide corporate contributions and community relations at Johnson & Johnson, writes in the Bill & Melinda Gates Foundation’s “Impatient Optimists” blog, adding, “Since then, text messages have been used to communicate all sorts of information. Most inspiring to me is how the technology once used to send a holiday wish is transforming the way women and families receive the information they need to be healthier — no matter where in the world they are.” She discusses several initiatives working with mobile technologies to improve health education and access, and states, “The ubiquity of the mobile phone provides the perfect method to deliver critical health information, as more than a billion women in low- and middle-income countries have access to a mobile phone” (12/20).
“Nigeria is one of only three countries — along with Afghanistan and Pakistan — that remains blighted by polio,” Aliko Dangote, founder and CEO of the Dangote Group and chair of the Dangote Foundation, writes in a Project Syndicate opinion piece. He notes Nigeria is “one of Africa’s most developed countries,” “the largest recipient of foreign direct investment in Africa,” home to “thriving Nigerian businesses,” and “will soon surpass South Africa to become Africaâ€™s largest economy.” However, “Nigerians cannot hope to lead Africa, economically or otherwise, while neglecting to eliminate preventable diseases like polio,” he writes.